
pmid: 647565
pmc: PMC1818259
Strongyloides stercoralis, a nematode not well known to many Canadian physicians, infects 35% of some tropical populations. Larvae can be isolated from the stools in 25% of cases and from duodenal aspirates in 95%. Treatment is with thiabendazole given twice daily in a dose of 25 mg/kg up to a maximum of 1.5 g/d. Frenquently an individual with a previously asymptomatic infection presents with hyperinfection and death rapidly ensues, but usually classical symptoms are present. Such a case is described. Immunosuppression is frequently associated with the hyperinfective state.
Canada, Thiabendazole, Strongyloides, Strongyloidiasis, Humans, Female, Intestinal Diseases, Parasitic, Middle Aged, United States
Canada, Thiabendazole, Strongyloides, Strongyloidiasis, Humans, Female, Intestinal Diseases, Parasitic, Middle Aged, United States
| citations The total number of citations received by all articles of the researcher of interest. | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
